Case 123 update 2

The plan is to commence treatment with DA+myelotarg

Cytogenetic and molecular studies show

t(8:21)

C-KIT positive

FLT3 negative

NPM1 negative

Would this change your management?

How are you going to monitor response in this patient?

About TeamHaem

Online education and discussion about all things haematological
This entry was posted in Uncategorised. Bookmark the permalink.